News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BENZENO SHARON
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
4
| BENZENO SHARON (Chief Commercial Ofc Imm Med) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 132,979 shares
@ $0
Sold 11,749 shares
@ $8.57, valued at
$100.7k
Granted 199,549 options to buy
@ $8.46, valued at
$1.7M
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 22,894 shares
@ $0
Granted 57,234 options to buy
@ $43.68, valued at
$2.5M
|
|
| 03/03/2021 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 416 shares
@ $61.2, valued at
$25.5k
Exercised 416 options to buy
@ $6.27, valued at
$2.6k
|
|
| 03/03/2021 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 6,210 shares
@ $57.57, valued at
$357.5k
Sold 561 shares
@ $58.17, valued at
$32.6k
Exercised 2,604 options to buy
@ $6.55, valued at
$17.1k
Exercised 1,563 options to buy
@ $7.27, valued at
$11.4k
|
|
| 02/17/2021 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 5,022 shares
@ $63.42, valued at
$318.5k
Sold 1,700 shares
@ $64.59, valued at
$109.8k
Sold 9,528 shares
@ $65.29, valued at
$622.1k
Exercised 16,250 options to buy
@ $31.71, valued at
$515.3k
|
|
| 02/03/2021 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 6,470 shares
@ $55.61, valued at
$359.8k
Sold 300 shares
@ $56.41, valued at
$16.9k
Exercised 2,604 options to buy
@ $6.55, valued at
$17.1k
Exercised 1,562 options to buy
@ $7.27, valued at
$11.4k
|
|
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 417 shares
@ $59.14, valued at
$24.7k
Exercised 417 options to buy
@ $6.27, valued at
$2.6k
|
|
| 12/02/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 3,077 shares
@ $48.2, valued at
$148.3k
Sold 3,693 shares
@ $49.43, valued at
$182.5k
Exercised 2,604 options to buy
@ $6.55, valued at
$17.1k
Exercised 1,562 options to buy
@ $7.27, valued at
$11.4k
|
|
| 11/23/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 416 shares
@ $48.86, valued at
$20.3k
Exercised 416 options to buy
@ $6.27, valued at
$2.6k
|
|
| 11/04/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 5,698 shares
@ $45.47, valued at
$259.1k
Sold 1,074 shares
@ $46.14, valued at
$49.6k
Exercised 2,605 options to buy
@ $6.55, valued at
$17.1k
Exercised 2,604 options to buy
@ $6.55, valued at
$17.1k
Exercised 1,563 options to buy
@ $7.27, valued at
$11.4k
|
|
| 10/20/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 417 shares
@ $51.25, valued at
$21.4k
Exercised 417 options to buy
@ $6.27, valued at
$2.6k
|
|
| 10/02/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 5,878 shares
@ $48.46, valued at
$284.8k
Sold 893 shares
@ $49.26, valued at
$44k
Exercised 2,604 options to buy
@ $6.55, valued at
$17.1k
Exercised 2,605 options to buy
@ $6.55, valued at
$17.1k
Exercised 1,562 options to buy
@ $7.27, valued at
$11.4k
|
|
| 09/23/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 417 shares
@ $45.51, valued at
$19k
Exercised 417 options to buy
@ $6.27, valued at
$2.6k
|
|
| 09/02/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 6,471 shares
@ $41.28, valued at
$267.1k
Sold 300 shares
@ $41.75, valued at
$12.5k
Exercised 2,604 options to buy
@ $6.55, valued at
$17.1k
Exercised 1,563 options to buy
@ $7.27, valued at
$11.4k
|
|
| 08/19/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 416 shares
@ $41.57, valued at
$17.3k
Exercised 416 options to buy
@ $6.27, valued at
$2.6k
|
|
| 08/05/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 7,187 shares
@ $40, valued at
$287.5k
Exercised 2,604 options to buy
@ $6.55, valued at
$17.1k
Exercised 1,562 options to buy
@ $7.27, valued at
$11.4k
Exercised 417 options to buy
@ $6.32, valued at
$2.6k
|
|
| 07/21/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 417 shares
@ $40, valued at
$16.7k
Exercised 417 options to buy
@ $6.27, valued at
$2.6k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 417 shares
@ $45, valued at
$18.8k
Exercised 417 options to buy
@ $6.27, valued at
$2.6k
|
|
| 06/05/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 6,770 shares
@ $40, valued at
$270.8k
Exercised 2,604 options to buy
@ $6.55, valued at
$17.1k
Exercised 1,562 options to buy
@ $7.27, valued at
$11.4k
|
|
| 05/28/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 416 shares
@ $42, valued at
$17.5k
Exercised 416 options to buy
@ $6.32, valued at
$2.6k
|
|
| 05/21/2020 |
4
| BENZENO SHARON (Chief Business Development Off) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 246,770 shares
@ $40, valued at
$9.9M
Exercised 60,000 options to buy
@ $1.98, valued at
$118.8k
Exercised 18,750 options to buy
@ $6.32, valued at
$118.5k
Exercised 15,416 options to buy
@ $6.27, valued at
$96.7k
Exercised 78,125 options to buy
@ $6.55, valued at
$511.7k
Exercised 49,479 options to buy
@ $6.55, valued at
$324.1k
Exercised 25,000 options to buy
@ $7.27, valued at
$181.8k
|
|
| 02/18/2020 |
4
| BENZENO SHARON (SVP, Drug Discovery) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 65,000 options to buy
@ $31.71, valued at
$2.1M
|
|
| 06/26/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|